U.S. Banks Stock News

How Hingham Institution for Savings' FY 2025 Numbers Set Up the Earnings Story Hingham Institution for Savings (HIFS) closed FY 2025 with fourth quarter total revenue of US$34.5 million and basic EPS of US$9.49, while trailing twelve month revenue reached US$102.8 million and EPS came in at US$25.01, setting a clear earnings marker for investors to work from. Over the past year, revenue has moved from US$65.5 million and EPS of US$12.95 on a trailing basis in Q4 2024 to US$102.8 million and...

If you are wondering whether Equinix at around US$801.78 is priced high, low, or somewhere in between, you are not alone. That is exactly what this article will unpack. The stock has seen a 0.2% move over the last 7 days, a 7.8% return over the last 30 days, a 4.9% return year to date, but a 10.4% decline over the last year. Taken together, this gives a mixed picture of recent sentiment. These shifts sit against a backdrop of ongoing interest in data centers and digital infrastructure, where...

Navient (NAVI) is back in focus after a leadership shake up that puts long time executive Steve Hauber in the Chief Financial Officer seat, consolidating oversight of finance, legal, risk and compliance. See our latest analysis for Navient. That reshuffle comes as Navient’s share price sits at US$12.51, with a 30 day share price return of 5.23% decline and a 1 year total shareholder return of 5.70% decline. This suggests recent momentum has softened even as investors weigh the upcoming 2025...

If you are wondering whether Hawkins at around US$152 is still attractively priced after a strong multi year run, this breakdown is designed to help you size up the current valuation with clear, practical checks. The share price has seen a 6.6% gain over the last 30 days, a 4.6% return year to date, and a 33.7% return over the past year, while the 3 year return is very large at close to 3x. These moves have drawn more attention to how the market is treating specialty chemical suppliers like...

On December 31, 2025, Range Resources Corporation announced it would fully redeem its US$600,000,000 8.25% senior notes due 2029 on January 15, 2026, at 101.375% of par plus accrued interest, funded via its existing revolving credit facility. This move retires high-coupon debt while shifting funding to shorter-term bank borrowing, putting the company’s balance sheet choices under closer investor and analyst scrutiny. Next, we’ll examine how funding this bond redemption through the revolving...

Earlier this week, Edgewise Therapeutics used its presentation at the 44th J.P. Morgan Healthcare Conference to outline 2026 milestones, including pivotal GRAND CANYON data for sevasemten in Becker muscular dystrophy, Phase 2 readouts for EDG-7500 in hypertrophic cardiomyopathy, and continued development of its early-stage heart failure candidate EDG-15400. A distinctive aspect of the update is Edgewise’s attempt to build an integrated neuromuscular and cardiovascular franchise, with...

Recent analyst reports on Marex Group (MRX) highlight increased optimism around the company’s earnings outlook. Several firms have revised their forecasts higher and reiterated positive ratings, drawing fresh attention to the stock. See our latest analysis for Marex Group. The recent earnings optimism has coincided with a 32.28% 90 day share price return and a 21.80% total shareholder return over the past year, suggesting momentum has been building around Marex Group, which had a last close...

Why Worthington Enterprises is on investors’ radar today Worthington Enterprises (WOR) has been drawing attention after a mixed stretch in recent trading, with the share price drifting lower over the past month and past 3 months while longer term returns remain positive. See our latest analysis for Worthington Enterprises. At around US$53.43, the share price has eased in the short term, with a 1 day share price return of a 2.0% decline and a 90 day share price return of a 5.5% decline, while...

M&T Bank (MTB) closed out FY 2025 with fourth quarter revenue of US$2.4 billion and basic EPS of US$4.71, alongside net income of US$718 million, framing a year where the trailing 12 month tally reached US$9.2 billion of revenue and US$17.10 in EPS. Over the past few quarters, revenue has moved from US$2.2 billion in Q4 2024 to US$2.4 billion in Q4 2025, while quarterly EPS increased from US$3.88 to US$4.71, supported by higher net income. This sets up a results season in which investors are...

In early January 2026, Rapport Therapeutics announced past and planned advances across its clinical pipeline, including preparing a Phase 3 program for RAP-219 in focal onset seizures, expanding into primary generalized tonic-clonic seizures, and resuming its Phase 2 diabetic peripheral neuropathic pain trial after the FDA lifted a clinical hold. A key insight is that Rapport is concentrating resources on programs it believes can meaningfully address unmet neurological needs while supporting...

North Dallas Bank & Trust (NODB) just wrapped up FY 2025 with fourth quarter total revenue of US$12.9 million and basic EPS of US$1.19, capping a trailing twelve month stretch that sums to US$48.0 million in revenue and EPS of US$3.35. Over the past few quarters, revenue has moved from US$9.8 million in Q3 2024 to US$12.9 million in Q4 2025. Quarterly EPS has ranged from US$0.20 in Q3 2024 to US$1.19 most recently, alongside reported profit growth of 166.6% and a net profit margin that...

If you are wondering whether Darling Ingredients is reasonably priced or offering a margin of safety right now, this article will walk through what the current share price might be implying about its value. The stock recently closed at US$39.57, with returns of 1.3% over 7 days, 14.4% over 30 days, 5.1% year to date, 8.0% over 1 year, and a 39.7% and 40.7% decline over 3 and 5 years respectively. Taken together, these figures give mixed signals about how the market has been treating the...

StubHub Holdings (STUB) is back in focus as multiple securities class action lawsuits over its 2025 IPO disclosures approach a January 23 lead plaintiff deadline, keeping legal and cash flow questions front and center for shareholders. See our latest analysis for StubHub Holdings. Recent trading reflects elevated uncertainty, with a 7 day share price return of 25.29% and a 30 day gain of 14.37% partly offsetting a 90 day share price return of negative 6.71%. The stock is at $16.0 with year to...

Event context and recent stock performance Indivior (INDV) has been on investors’ radar after recent share price swings, with the stock showing a 1 day return of 1.05% and a 7 day decline of 8.18%. Over the past month the share price return is a 9.49% decline, contrasting with a 32.92% gain over the past 3 months. This may prompt investors to reassess how current pricing lines up with Indivior’s fundamentals. See our latest analysis for Indivior. At a share price of US$32.54, Indivior’s...

Event context for Accelerant Holdings Accelerant Holdings (ARX) has drawn investor attention after recent share price moves, with the stock showing a negative 1 day return of 2.1% and a negative 7 day return of 4.8%. Over the past month the stock posted a negative return of 4.5%. Over the past 3 months it shows a 16.4% gain, setting up a contrast that raises questions about how investors are weighing its growing revenue and current net loss. See our latest analysis for Accelerant Holdings. At...

Ouster recently presented at the 28th Annual Needham Growth Conference on January 15, 2026, at The Lotte New York Palace Hotel in New York, where CEO Angus Pacala, Senior VP of Strategic Finance & Treasurer Chen Geng, and CFO Kenneth P. Gianella addressed attendees. This high-profile conference appearance gave Ouster’s leadership a platform to communicate its roadmap and capital allocation priorities directly to institutional investors and analysts. We’ll now examine how Ouster’s Needham...

Xencor (XNCR) recently outlined 2026 priorities for its XmAb platform, highlighting early clinical data for renal cell carcinoma candidate XmAb819 and setting out timelines for multiple oncology and autoimmune milestones that could influence investor expectations. See our latest analysis for Xencor. Despite the fresh 2026 pipeline update, Xencor’s recent share price momentum has been weak, with a 30 day share price return of a 19.05% decline and a 1 year total shareholder return of a 33.52%...

In mid-January 2026, High Roller Technologies, Inc. announced a binding Letter of Intent with Crypto.com | Derivatives North America to power a regulated, event-based prediction markets product in the United States, alongside multiple non-binding marketing LOIs with social-first sports media platforms to support its planned launch. A distinctive aspect of this move is High Roller’s effort to pair regulated prediction-market infrastructure with billion-scale social media reach from partners...

WaFd (WAFD) opened fiscal Q1 2026 with total revenue of US$187.9 million and basic EPS of US$0.79, while trailing twelve month revenue stood at US$734.5 million and EPS at US$2.89, giving investors a clear view of both the latest quarter and the broader earnings run rate. Over recent quarters, the bank has seen revenue move from US$171.1 million in Q1 2025 to US$187.9 million in Q1 2026, with quarterly EPS shifting from US$0.54 to US$0.79 across the same period, setting up this result against...

Earlier this month, Enerpac Tool Group Corp. presented at CJS Securities’ 26th Annual “New Ideas for the New Year” Investor Conference on January 14, 2026, and has since attracted fresh analyst attention. William Blair’s initiation of coverage with a “Market Perform” rating adds another professional viewpoint to existing research, potentially broadening institutional interest and debate around Enerpac’s prospects. Next, we’ll examine how William Blair’s new coverage could influence Enerpac...

Westamerica Bancorporation (WABC) has wrapped up FY 2025 with fourth quarter revenue of US$63.3 million and basic EPS of US$1.12, alongside net income of US$27.8 million, providing a clear snapshot of its latest run rate. The bank has seen quarterly revenue shift from US$73.9 million in Q3 2024 to US$63.3 million in Q4 2025, with basic EPS moving from US$1.31 to US$1.12 over the same stretch. Trailing twelve month revenue for Q4 2025 is US$258.4 million and EPS is US$4.52. In that context,...

What Jefferson Capital’s recent trading signals tell you Recent trading in Jefferson Capital (JCAP) has drawn attention after a mixed pattern of short term declines alongside gains over the past month and past 3 months, prompting investors to reassess how its fundamentals line up with sentiment. See our latest analysis for Jefferson Capital. With the share price at $22.55, Jefferson Capital’s recent 1 day and 7 day share price declines contrast with a stronger 30 day and especially 90 day...

It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.9x right...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...